BioMarin Pharmaceutical Inc. buy Sanford C. Bernstein
Start price
17.09.24
/
50%
€62.80
Target price
17.09.25
€80.87
Performance (%)
-26.54%
End price
18.09.25
€46.13
Summary
This prediction ended on 18.09.25 with a price of €46.13. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.54%. Sanford_C__Bernstein has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Sanford_C__Bernstein has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.838% | -0.838% | -23.131% |
| iShares Core DAX® | 0,02 % | 0,58 % | 11,67 % |
| iShares Nasdaq 100 | 1,74 % | -2,06 % | 4,18 % |
| iShares Nikkei 225® | 0,43 % | 10,49 % | 29,99 % |
| iShares S&P 500 | 1,33 % | 0,14 % | 3,33 % |
Comments by Sanford_C__Bernstein for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Sanford C. Bernstein from $116.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Sanford_C__Bernstein gewählte maximale Laufzeit wurde überschritten
Current prediction by Sanford_C__Bernstein for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€52.42
25.02.26
25.02.26
€79.75
25.02.27
25.02.27
-0.72%
25.02.26
25.02.26
Stopped prediction by Sanford_C__Bernstein for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€85.64
20.08.24
20.08.24
€99.09
20.08.25
20.08.25
-42.16%
21.08.25
21.08.25